Blood eosinophil counts as markers of response to inhaled corticosteroids in COPD?
Boehringer Ingelheim Pharma GmbH & Co KG, Medicine TA Respiratory Diseases, 55216 Ingelheim, Germany. Electronic address: lars.groenke@boehringer-ingelheim.com.
Lars
L
Groenke
Boehringer Ingelheim Pharma GmbH & Co KG, Medicine TA Respiratory Diseases, 55216 Ingelheim, Germany.
Bernd
B
Disse
D000730:Androstadienes / Q000627:therapeutic use*; D001592:Benzyl Alcohols / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002722:Chlorobenzenes / Q000627:therapeutic use*; D004804:Eosinophils / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D029424:Pulmonary Disease, Chronic Obstructive / Q000097:blood* / Q000188:drug therapy*
D000730:Androstadienes; D001592:Benzyl Alcohols; D001993:Bronchodilator Agents; D002722:Chlorobenzenes